Scalper1 News
Big pharma Eli Lilly (LLY) guided 2016 below Wall Street’s expectations Tuesday, but the stock rose after falling along with the big market plunge on Monday. Lilly said it expects revenue of $20.2 billion to $20.7 billion, up a fraction from last year’s estimated sales but below analysts’ consensus of $21.36 billion, according to Thomson Reuters. Earnings excluding one-time items were guided at $3.45 to $3.55 a share, also missing the Street’s Scalper1 News
Scalper1 News